Parkinson's disease is a common neurodegenerative disorder with a mainly sporadic
aetiology, although a number of monogenic familiar forms are known. Most of the motor …

Placebo administration is known to affect the brain both in pain and in Parkinson disease.
Here we show that placebo treatment caused reduced activity in single neurons in the …

OBJECTIVE To investigate the relation between the variation of the parameters of
stimulation and the clinical effectiveness in parkinsonian patients treated with deep brain …

We tested both pain thresholds and pain tolerance in patients with Alzheimer's disease (AD)
by means of phasic and tonic noxious stimuli. In the first case, electrical stimulation was …

Protein expression has been compared in human substantia nigra specimens from
Parkinson's disease (PD) patients and from controls, and 44 proteins expressed in this …

Objective: To evaluate modifications occurring in cognitive functions and behavioural
aspects in a group of 72 consecutive patients with Parkinson's disease (PD) 15 months after …

We conducted a double-blind trial of high-dose parenteral 6-methylprednisolone (MP) and
placebo on 23 patients with acute MS. After the double-blind trial, the patients were given …

Objective: This study was aimed at analyzing the degree of intercostal nerve impairment in
posterolateral and muscle-sparing thoracotomy and at correlating the nerve damage to the …

The aim of our study was to evaluate the etiopathogenesis and the vascular risk factors in a
consecutive series of patients with juvenile ischemic stroke. We enrolled 273 patients (158 …

Objectives: Bilateral chronic high frequency stimulation of the subthalamic nucleus (STN),
through the stereotactical placement of stimulating electrodes, effectively improves the motor …